An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates

por Zabaleta, Nerea, Dai, Wenlong, Bhatt, Urja, Hérate, Cécile, Maisonnasse, Pauline, Chichester, Jessica A., Sanmiguel, Julio, Estelien, Reynette, Michalson, Kristofer T., Diop, Cheikh, Maciorowski, Dawid, Dereuddre-Bosquet, Nathalie, Cavarelli, Mariangela, Gallouët, Anne-Sophie, Naninck, Thibaut, Kahlaoui, Nidhal, Lemaitre, Julien, Qi, Wenbin, Hudspeth, Elissa, Cucalon, Allison, Dyer, Cecilia D., Pampena, M. Betina, Knox, James J., LaRocque, Regina C., Charles, Richelle C., Li, Dan, Kim, Maya, Sheridan, Abigail, Storm, Nadia, Johnson, Rebecca I., Feldman, Jared, Hauser, Blake M., Contreras, Vanessa, Marlin, Romain, Tsong Fang, Raphaël Ho, Chapon, Catherine, van der Werf, Sylvie, Zinn, Eric, Ryan, Aisling, Kobayashi, Dione T., Chauhan, Ruchi, McGlynn, Marion, Ryan, Edward T., Schmidt, Aaron G., Price, Brian, Honko, Anna, Griffiths, Anthony, Yaghmour, Sam, Hodge, Robert, Betts, Michael R., Freeman, Mason W., Wilson, James M., Le Grand, Roger, Vandenberghe, Luk H.
Publicado 2021